This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Menopause is diagnosed after 12 months of amenorrhoea; the final menstrual period is retrospectively defined.1
Onset of the menopause transition is best determined by menstrual-cycle monitoring. Vasomotor symptoms may begin well before the last menstrual period.2
Hormone testing is generally not recommended as a way to determine a woman’s menopausal status, as ovarian function is erratic during the menopause transition.3 If premature ovarian insufficiency (POI) is suspected in a woman < 40 years, then follicle-stimulating hormone (FSH) levels can be tested to diagnose the condition (requires a minimum of 2 elevated FSH results [> 40 IU/L] at least 4-6 weeks apart).1
It is vital to have effective communication skills during a menopause consultation. A few things to bear in mind:
Download a Symptoms Score Sheet to help diagnose menopause and understand the patient's symptoms. This can be a useful tool to complete together in order to understand the impact HRT is having on the patient.
References
Discover common symptoms of menopause to help understand the condition and reassure patients
Learn recommendations to support patients with their lifestyle, diet and exercise, core recommendations regarding hormone replacement therapy (HRT), appropriate candidates for HRT, benefit-risk profile of HRT and Bioidentical Hormone Therapy
Discover an overview of options with systemic and local therapies
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2023 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021